课题基金 / 基金详情

1/3 Alcohol Research Consortium in HIV - Administrative Core (ARCH-AC)

1/3 Alcohol Research Consortium in HIV - Administrative Core (ARCH-AC)
1/3 HIV 酒精研究联盟 - 行政核心 (ARCH-AC)
批准号:
10426405
负责人:
GEETANJALI CHANDER
金额:
$11.11万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-15 至 2023-08-31

项目摘要

项目成果

GEETANJALI CHANDER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This competitive renewal application for the Alcohol Research Consortium on HIV (ARCH) builds on and extends our very successful administrative and research accomplishments during our initial NIAAA funding period. ARCH is integrated into a well-established, scientifically productive, national HIV clinical cohort, the CFAR Network of Integrated Clinical systems (CNICS), a network of 8 clinical cohorts and over 30,000 persons living with HIV (PLWH) across the United States. This dynamic cohort provides an ideal scientific platform for long-term study of HIV and alcohol through the collection of comprehensive clinical data and specimens as well as uniformly-collected patient reported outcomes. The ARCH consortium consists of the Administrative Core (ARCH-AC), the epidemiological research component (ARCH-ERA), and an intervention research component (ARCH- IRA). In addition, we have embedded a nascent resource core into each of the research components to capitalize on our expertise and expand our capacity in two new and critical areas of high relevance to HIV and alcohol services and research: the Biostatistics Core (housed in the epidemiology grant ARCH-ERA) and an eHealth Technology Core (housed in the intervention grant ARCH-IRA). The overarching goal of our consortium is to improve clinical outcomes and reduce health disparities among PLWH with alcohol misuse through development and testing of tailored interventions (ARCH-IRA) that are informed by real-time data collection and analysis (ARCH-ERA). Specific themes addressed by our consortium include health disparities, precision medicine, implementation science, state-of-the-art biostatistical methodology, and eHealth technology. The ARCH Administrative Core (AC), the focus of this application, is the U24 that provides the infrastructure for oversight, coordination and direction to the consortium, and facilitates the scientific goals of the epidemiology and intervention components of ARCH. The structure includes: an executive committee; a research steering committee which includes a scientific advisory board; key scientific working groups to conceptualize and implement study aims. ARCH-AC is co-led by national experts in alcohol use disorders and HIV, who have over 30 years of combined scientific experience in conducting epidemiologic and clinical research in HIV/AIDS. The AC provides the critical infrastructure to: 1)Facilitate communication, collaboration and integration among ARCH components and investigators, NIAAA collaborators, Scientific Advisory Board, CHAART and other alcohol/HIV consortia; 2)Oversee implementation of the ARCH scientific epidemiologic and interventional aims; 3)Optimize coordination of ARCH resources among the research projects and with outside groups, particularly the data repositories, epidemiologic/ biostatistics support and the investigational expertise; 4)Promote scientific participation of junior investigators new to the field of alcohol and or HIV; 5)Support dissemination of information by ARCH investigators through presentations, publications, web site maintenance and other strategies for public communication.
期刊论文(15)
专著(0)
科研奖励(0)
会议论文
DOI: 10.18632/oncotarget.16449
发表时间: 2017-05-02
期刊: Oncotarget
影响因子: --
作者: [Yang L, Liu Y, Zhang N, Ding X, Zhang W, Shen K, Huang L, Zhou J, Cui S, Zhu Z, Hu Z, Xiao M]
通讯作者: Xiao M
DOI: 10.18632/oncotarget.4737
发表时间: 2015-09-29
期刊: Oncotarget
影响因子: --
作者: [Li Y, Li Y, Chen W, He F, Tan Z, Zheng J, Wang W, Zhao Q, Li J]
通讯作者: Li J
NDRG4 stratifies the prognostic value of body mass index in colorectal cancer.
NDRG4 对体重指数在结直肠癌中的预后价值进行分层
DOI: 10.18632/oncotarget.6182
发表时间: 2016-01-12
期刊: Oncotarget
影响因子: --
作者: [Zheng J, Li Y, Zhu S, Li J, Zhao Q, Ji G, Wang W, Chu D]
通讯作者: Chu D
DOI: 10.1155/2018/5408324
发表时间: 2018
期刊: Journal of immunology research
影响因子: 4.1
作者: [Fan H, Jiang C, Zhong B, Sheng J, Chen T, Chen Q, Li J, Zhao H]
通讯作者: Zhao H
11
    HIV and Substance Use Cohort Coordinating Center for Emerging and High Impact Scientific Cross Cohort Studies: HIV SUCCESS
    • 批准号:
      10676432
    • 项目类别:
    • 资助金额:
      $93.9万
    • 财政年份:
      2023
    • 负责人:
      GEETANJALI CHANDER
    • 依托单位:
    Training in Equity and Structural Solutions in Addictions (TESSA)
    • 批准号:
      10625735
    • 项目类别:
    • 资助金额:
      $19.36万
    • 财政年份:
      2023
    • 负责人:
      GEETANJALI CHANDER
    • 依托单位:
    Mentoring and Patient Oriented Research at the Nexus of Unhealthy Alcohol Use and HIV
    • 批准号:
      10608555
    • 项目类别:
    • 资助金额:
      $17.39万
    • 财政年份:
      2022
    • 负责人:
      GEETANJALI CHANDER
    • 依托单位:
    Mentoring and Patient Oriented Research at the Nexus of Unhealthy Alcohol Use and HIV
    • 批准号:
      10685992
    • 项目类别:
    • 资助金额:
      $16.86万
    • 财政年份:
      2022
    • 负责人:
      GEETANJALI CHANDER
    • 依托单位:
    海外基金